Mauch C - Search Results

1

Risikofaktoren für Rezidive des malignen Melanoms bei Patienten mit negativer Wächterlymphknotenbiopsie.

Persa OD, Knuever J, Mauch C. Persa OD, et al. Among authors: mauch c. J Dtsch Dermatol Ges. 2019 Sep;17(9):951-954. doi: 10.1111/ddg.13879_g. J Dtsch Dermatol Ges. 2019. PMID: 31538730 German. No abstract available.

2

Risk factors for recurrence of malignant melanoma in patients with negative sentinel lymph node biopsy.

Persa OD, Knuever J, Mauch C. Persa OD, et al. Among authors: mauch c. J Dtsch Dermatol Ges. 2019 Sep;17(9):951-954. doi: 10.1111/ddg.13879. Epub 2019 Jun 20. J Dtsch Dermatol Ges. 2019. PMID: 31219663 No abstract available.

3

Sequencing of immunotherapy and targeted therapy for BRAF^V600 mutated melanoma: a retrospective study.

Persa OD, Fromme JE, Mauch C. Persa OD, et al. Among authors: mauch c. J Dtsch Dermatol Ges. 2021 Jun;19(6):902-904. doi: 10.1111/ddg.14329. Epub 2021 Feb 22. J Dtsch Dermatol Ges. 2021. PMID: 33617147 No abstract available.

4

Therapiesequenz von Immuntherapie und zielgerichteter Therapie beim BRAF^V600 -mutierten malignen Melanom: eine retrospektive Studie.

Persa OD, Fromme JE, Mauch C. Persa OD, et al. Among authors: mauch c. J Dtsch Dermatol Ges. 2021 Jun;19(6):902-905. doi: 10.1111/ddg.14329_g. J Dtsch Dermatol Ges. 2021. PMID: 34139097 German. No abstract available.

5

Komplette Plattenepithelkarzinom-Exzision ist der Strahlentherapie residualer mikroskopischer Tumorzellreste überlegen.

Persa OD, Mauch C. Persa OD, et al. Among authors: mauch c. J Dtsch Dermatol Ges. 2022 Jul;20(7):1020-1022. doi: 10.1111/ddg.14780_g. J Dtsch Dermatol Ges. 2022. PMID: 35881097 No abstract available.

6

[What is new in the diagnosis and therapy of malignant melanoma?].

Persa OD, Mauch C. Persa OD, et al. Among authors: mauch c. Dtsch Med Wochenschr. 2020 Dec;145(24):1754-1756. doi: 10.1055/a-1012-2972. Epub 2020 Nov 30. Dtsch Med Wochenschr. 2020. PMID: 33254249 German.

7

Complete excision of squamous cell carcinoma is superior to salvage radiotherapy for microscopic residual disease.

Persa OD, Mauch C. Persa OD, et al. Among authors: mauch c. J Dtsch Dermatol Ges. 2022 Jul;20(7):1020-1022. doi: 10.1111/ddg.14780. Epub 2022 May 17. J Dtsch Dermatol Ges. 2022. PMID: 35581694 No abstract available.

8

The use of circulating cell-free tumor DNA in routine diagnostics of metastatic melanoma patients.

Knuever J, Weiss J, Persa OD, Kreuzer K, Mauch C, Hallek M, Schlaak M. Knuever J, et al. Among authors: mauch c. Sci Rep. 2020 Mar 18;10(1):4940. doi: 10.1038/s41598-020-61818-1. Sci Rep. 2020. PMID: 32188904 Free PMC article.

9

Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.

Persa OD, Knuever J, Mauch C, Schlaak M. Persa OD, et al. Among authors: mauch c. J Dermatol. 2018 Oct;45(10):1191-1194. doi: 10.1111/1346-8138.14577. Epub 2018 Aug 10. J Dermatol. 2018. PMID: 30095864

10

Predicting risk for seroma development after axillary or inguinal sentinel lymph node biopsy in melanoma patients.

Persa OD, Knuever J, Rose A, Mauch C, Schlaak M. Persa OD, et al. Among authors: mauch c. Int J Dermatol. 2019 Feb;58(2):185-189. doi: 10.1111/ijd.14247. Epub 2018 Sep 19. Int J Dermatol. 2019. PMID: 30229888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters